The Road Ahead: An Update on Investigational Agents and Strategies for HCV Management

In this downloadable slideset, Raymond T. Chung, MD, reviews challenges with current HCV therapies and emerging treatment strategies with novel HCV agents.
Format: Microsoft PowerPoint (.ppt)
File Size: 2.18 MB
Released: December 12, 2012

Acknowledgements

Educational grant provided by:
Janssen Therapeutics

Related Content

Downloadable slides from CCO expert, Dr. Alain H. Litwin, on integrating HCV and HIV prevention and care strategies into addiction care settings

Alain H. Litwin, MD Released: September 18, 2020

Dr. Stefan Zeuzem discusses new viral hepatitis data reported at the 2020 Digital International Liver Congress, in the CCO Infectious Disease podcast

Stefan Zeuzem, MD Released: September 14, 2020

Expert selections of the most important viral hepatitis data from EASL 2020, including HCV elimination and HCV and HBV treatment, provided by CCO

Stefan Zeuzem, MD Released: September 8, 2020

Latest data and best practice guidance on treating HCV in addiction medicine settings published by Clinical Care Options (CCO)

Andrew Seaman, MD Released: February 24, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue